DTC Genetics Services Hit Hard on the Hill as FDA Mulls Options

Overshadowed by a smarting GAO report on DTC genetics firms' failings, FDA suggests to lawmakers that it may be developing a new approach for regulating consumer genetics companies.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.